Document is current
Any future updates will be listed below
-
Authors
McGurk, Kathryn A. https://orcid.org/0000-0002-5445-6906
Qiao, Mengyun
Zheng, Sean L. https://orcid.org/0000-0002-5762-6392
Sau, Arunashis
Henry, Albert https://orcid.org/0000-0001-7422-2288
Ribeiro, Antonio Luiz P.
Ribeiro, Antônio H. https://orcid.org/0000-0003-3632-8529
Ng, Fu Siong https://orcid.org/0000-0002-8681-4368
Lumbers, R. Thomas https://orcid.org/0000-0002-9077-4741
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
Ware, James S. https://orcid.org/0000-0002-6110-5880
O’Regan, Declan P. https://orcid.org/0000-0002-0691-0270
-
Funding
Funding for this research was provided by:
British Heart Foundation (RG/19/6/34387, CH/P/23/80008, RG/F/22/110078, FS/IPBSRF/22/27059, RG/F/22/110078)
RCUK | Medical Research Council (MC_UP_1605/13)
Foundation for the National Institutes of Health (5R01HL167509-02)
RCUK | Engineering and Physical Sciences Research Council (EP/W01842X/1)
Sir Jules Thorn Charitable Trust (21JTA)
Wellcome Trust ([107469/Z/15/Z)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 22 October 2024
First Online: 20 November 2024
Competing interests
: D.P.O. has consulted for Bayer AG and Bristol-Myers Squibb. J.S.W. has consulted for MyoKardia, Inc., Pfizer, Foresite Labs, Health Lumen and Tenaya Therapeutics and has received research support from Bristol-Myers Squibb. R.T.L. has consulted for Health Lumen and FITFILE. None of these activities are directly related to the work presented here. The other authors declare no competing interests.
